CX3CR1 as a target for airways inflammation

Author： Doggrell Sheila A  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.15, Iss.9, 2011-09, pp. : 1139-1142

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fractalkine/CX3CR1 Signalling in Chronic Pain and Inflammation

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 10, 2011-10 ,pp. : 1707-1714

Bentham Science Publishers

Access to resources Recommend Favorite

CX3CL1/CX3CR1 Axis, as the Therapeutic Potential in Renal Diseases: Friend or Foe?

By  

Current Gene Therapy, Vol. 17, Iss. 6, 2018-03 ,pp. : 442-452

Bentham Science Publishers

Access to resources Recommend Favorite

Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential

By D'Haese Jan G   Demir Ihsan Ekin   Friess Helmut   Ceyhan Güralp O  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 2, 2010-02 ,pp. : 207-219

Informa Healthcare

Access to resources Recommend Favorite

IL-1 as a target in inflammation

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 15, Iss. 3, 2015-01 ,pp. : 206-211

Bentham Science Publishers

Access to resources Recommend Favorite

Oxidative stress and lung inflammation in airways disease

By MacNee W.  

European Journal of Pharmacology, Vol. 429, Iss. 1, 2001-10 ,pp. : 195-207

Elsevier

Access to resources Recommend Favorite